UNLIMITED TURBO BULL - BIOGEN IDEC | Real-time Euronext Paris 01:53:06 14/05/2024 pm IST | ||
| 1.685 EUR | +1.81% |
|
| Current month | +6.43% | ||
| 1 month | +32.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/24/14 | 1.685 | +1.81% | 3 |
| 13/24/13 | 1.655 | +1.22% | 28 |
| 10/24/10 | 1.635 | +1.87% | 30 |
| 09/24/09 | 1.605 | +0.63% | 20 |
| 08/24/08 | 1.595 | +3.91% | 26 |
Real-time Euronext Paris
Last update May 14, 2024 at 01:53 pm IST
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Société Générale
|
| A818S | |
| ISIN | DE000SU1ASR7 |
| Date issued | 27/10/2023 |
| Strike | 135.1 $ |
| Maturity | Unlimited |
| Parity | 50 : 1 |
| Emission price | 2.33 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.54 € |
|---|---|
| Lowest since issue | 1.035 € |
| Spread | 0.04 € |
| Spread % | 2.35% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
225.3
USD
Average target price
285.9
USD
Spread / Average Target
+26.88%
- Stock Market
- Certificates
- A818S Certificat
